Alterity Therapeutics Limited

DB:PBN Stock Report

Market Cap: €9.9m

Alterity Therapeutics Balance Sheet Health

Financial Health criteria checks 5/6

Alterity Therapeutics has a total shareholder equity of A$13.8M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$19.2M and A$5.4M respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$12.64m
EquityAU$13.80m
Total liabilitiesAU$5.43m
Total assetsAU$19.22m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: PBN's short term assets (A$19.0M) exceed its short term liabilities (A$5.4M).

Long Term Liabilities: PBN's short term assets (A$19.0M) exceed its long term liabilities (A$51.9K).


Debt to Equity History and Analysis

Debt Level: PBN is debt free.

Reducing Debt: PBN had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PBN has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if PBN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies